实用医药杂志
實用醫藥雜誌
실용의약잡지
Practical Journal of Medicine & Pharmacy
2009年
7期
17-18,21
,共3页
车润平%张欣%王庆新%葛蕤%费圣强%庞秀丽%刘晓江
車潤平%張訢%王慶新%葛蕤%費聖彊%龐秀麗%劉曉江
차윤평%장흔%왕경신%갈유%비골강%방수려%류효강
布托啡诺%全麻%躁动%预防%治疗
佈託啡諾%全痳%躁動%預防%治療
포탁배낙%전마%조동%예방%치료
Butorphanol General anasethesia Agitation Prophylaxis Treatment
目的 评价布托啡诺用干预防和治疗全麻患者术后躁动的有效性与安全性.方法 ASA Ⅰ~Ⅱ级上腹部择期手术患者40例,随机分为对照(C)组与布托啡诺(B)组,每组20例.在术毕停用麻醉药即刻,C组经静脉注射生理盐水2ml;B组静脉注射布托啡诺0.02mg/kg.记录停用麻醉药前、拔管即刻、拔管后5min时的心率、血压,并对循环稳定程度、躁动程度、镇静状态进行评分.结果 与麻醉前相比,拔管时、拔管后5min对照组患者血压明显升高(P<0.05)、心率加快(P<0.05),而布托啡诺组血压、心率相对平稳,两组比较有显著性差异(P<0.05).与C组比较布托啡诺组躁动发生率更低(P<0.05),患者安静(P<0.05).C组有6例患者术后持续躁动,经静脉注射布托啡诺0.02mg/kg,症状控制率达83.33%.结论 布托啡诺是全麻术后躁动预防与治疗理想的选择药物.
目的 評價佈託啡諾用榦預防和治療全痳患者術後躁動的有效性與安全性.方法 ASA Ⅰ~Ⅱ級上腹部擇期手術患者40例,隨機分為對照(C)組與佈託啡諾(B)組,每組20例.在術畢停用痳醉藥即刻,C組經靜脈註射生理鹽水2ml;B組靜脈註射佈託啡諾0.02mg/kg.記錄停用痳醉藥前、拔管即刻、拔管後5min時的心率、血壓,併對循環穩定程度、躁動程度、鎮靜狀態進行評分.結果 與痳醉前相比,拔管時、拔管後5min對照組患者血壓明顯升高(P<0.05)、心率加快(P<0.05),而佈託啡諾組血壓、心率相對平穩,兩組比較有顯著性差異(P<0.05).與C組比較佈託啡諾組躁動髮生率更低(P<0.05),患者安靜(P<0.05).C組有6例患者術後持續躁動,經靜脈註射佈託啡諾0.02mg/kg,癥狀控製率達83.33%.結論 佈託啡諾是全痳術後躁動預防與治療理想的選擇藥物.
목적 평개포탁배낙용간예방화치료전마환자술후조동적유효성여안전성.방법 ASA Ⅰ~Ⅱ급상복부택기수술환자40례,수궤분위대조(C)조여포탁배낙(B)조,매조20례.재술필정용마취약즉각,C조경정맥주사생리염수2ml;B조정맥주사포탁배낙0.02mg/kg.기록정용마취약전、발관즉각、발관후5min시적심솔、혈압,병대순배은정정도、조동정도、진정상태진행평분.결과 여마취전상비,발관시、발관후5min대조조환자혈압명현승고(P<0.05)、심솔가쾌(P<0.05),이포탁배낙조혈압、심솔상대평은,량조비교유현저성차이(P<0.05).여C조비교포탁배낙조조동발생솔경저(P<0.05),환자안정(P<0.05).C조유6례환자술후지속조동,경정맥주사포탁배낙0.02mg/kg,증상공제솔체83.33%.결론 포탁배낙시전마술후조동예방여치료이상적선택약물.
Objective To evaluate the prophylaxis and treatment effects of butorphano on the emergence agitation after general anasethesia operation. Method The 40 patients subjected to epigast surgery were divided into two groups (20 patients in each group) randomly: butorphanol group, control group. When stopped ananaesthetic use in the ending operation butorphanol group received immediately intravenous injection of butorphanol 0.02mg/kg, control group intravenous injection of physiological saline 2ml. Result Compared with the anaesthesia before, after cupping, the cupping the 5 min, in control group patients' SBP had obvious ascension (P<0.05), the heart rate speeded up (P<0.05); But in butorphanol group SBP, the heart rate was all steady, between two groups there had the significant difference (P<0.05); compared to control group, emergence agitation formation rate of butorphanol group was lower (P<0.05), the patients were silence. The six patients in control group emerge unremitting agitation, viaintravenous injection of butorphano 0.02mg/kg, their symptom relief rate was up to 83.33%. Conclusion Butorphano is an ideal drug for prophylaxis and treatment of the emergence agitation after general anaesthesia.